Clinicopathologic Features and Kidney Outcomes in Primary Antiphospholipid Syndrome-Associated Nephropathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0842; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Rituximab-based regimens were used in 63.6% of cases, while complement inhibition was reserved for severe or refractory disease in 18.2%...Conclusion Primary APS-associated nephropathy is predominantly characterized by chronic microvascular and endothelial injury patterns with frequent chronic TMA-related lesions. Despite heterogeneous presentations, most patients achieved renal stabilization under multimodal therapy, although persistent chronic kidney disease burden remained substantial."
Clinical • Acute Kidney Injury • Cardiovascular • Chronic Kidney Disease • Genetic Disorders • Glomerulonephritis • Hematological Disorders • Hypertension • Nephrology • Renal Disease
|
|
Irina Lucia Bercaru; Alexandru Radu Iercosan; Stefan Nicolaie Lujinschi; Gener Ismail
|